GBM is considered a “cold tumor” characterized by a more immunosuppressive microenvironment, with poor T-cell infiltration, high bone marrow infiltration, and low PD-L1/PD-1 expression (35, 36). This evidence concerns the gene CD274 and glioblastoma.